ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 59 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | 0.0% | 395 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 395 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 395 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 395 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 395 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 395 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 395 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | +100.0% | 395 | +146.9% | 0.00% | – |
| Q3 2021 | $1,000 | – | 160 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 160 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 160 | -47.4% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 304 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 304 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 304 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -66.7% | 304 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | +50.0% | 304 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 304 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |